Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID‐19 pandemic-Reference-Cited by-同舟云学术

Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID‐19 pandemic

Published:2020-06-08 Issue:7 Volume:37 Page:1214-1216
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Rayman G.¹^ORCID,Lumb A.²^ORCID,Kennon B.³,Cottrell C.⁴,Nagi D.⁵,Page E.¹^ORCID,Voigt D.⁶,Courtney H.⁷,Atkins H.⁸,Platts J.⁹,Higgins K.⁹,Dhatariya K.¹⁰^ORCID,Patel M.¹¹^ORCID,Narendran P.¹²,Kar P.¹³¹⁴,Newland‐Jones P.¹⁵,Stewart R.¹⁶^ORCID,Burr O.¹⁷,Thomas S.¹⁸

Affiliation:

1. The Ipswich Hospital and Ipswich Diabetes Centre and Research Unit East Suffolk and North Essex NHS Foundation Trust Colchester UK

2. Oxford University Hospitals NHS Foundation Trust OCDEM Oxford UK

3. Department of Diabetes Queen Elizabeth University Hospital Glasgow Scotland

4. Diabetes Swansea Bay University Health Board Port Talbot UK

5. Diabetes Mid Yorkshire Hospitals NHS Trust Wakefield UK

6. Tayside University Hospitals NHS Trust Ninewells Hospital Dundee Scotland

7. Diabetes Belfast Health and Social Care Trust Belfast UK

8. Diabetes University Hospitals of Leicester NHS Trust Leicester UK

9. College of Medicine Cardiff and Vale University Local Health Board Cardiff UK

10. Elsie Bertram Diabetes Centre Norfolk & Norwich University Hospital NHS Foundation Trust Norwich UK

11. Diabetes University Hospital Southampton NHS Trust Southampton UK

12. Diabetes Queen Elizabeth Hospital Birmingham Birmingham UK

13. Portsmouth Hospitals NHS trust Portsmouth UK

14. NHS Diabetes Programme NHS England London UK

15. Diabetes and Endocrinology University of Southampton Faculty of Medicine Southampton UK

16. Diabetes Wrexham Maelor HospitalBetsi Cadwaladr University Health Board Wrexham UK

17. Diabetes Diabetes UK London UK

18. Diabetes Centre Guy's and Saint Thomas' NHS Foundation Trust London UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dme.14328

Reference3 articles.

1. BornsteinSR RubinoF KhuntiK MingroneG HopkinsD BirkenfeldALet al.Practical recommendations for the management of diabetes in patients with COVID‐19. Lancet Diabetes Endocrinol 2020 Published Online April 23 2020 https://doi.org/10.1016/:S2213‐8587(20)30152‐2

2. Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis;Andrade‐Castellanos CA;Cochrane Database Syst Rev,2016

3. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Effects of Hyperglycemia on SARS-CoV-2 Entry Mechanisms in Pancreatic Beta Cells;Viruses;2024-08-02

2. Acute Metabolic Complications of Diabetes;Textbook of Diabetes;2024-01-12

3. Association of COVID-19 outcomes with diabetes in the Veneto region (north-east italy): Epidemiological insights for the endemic phase?;Nutrition, Metabolism and Cardiovascular Diseases;2023-11

4. Clinical characteristics and acute complication of COVID-19 patients with diabetes: a multicenter, retrospective study in Southern China;Frontiers in Endocrinology;2023-08-14

5. Risks associated with acute pancreatitis (AP) with diabetic ketoacidosis (DKA) in COVID-19 patients: a literature review;Journal of Diabetes & Metabolic Disorders;2023-04-08